In brief: research round-upMedical Physics Web (subscription)Radio-immunotherapy with the low-energy beta emitter 177Lu-DOTA-rituximab is safe and effective for lymphoma patients, according to a study from Kantonsspital Baselland and University Hospita…
|
Steroid-free treatment of lupus nephritis a reality
Rheumatology Update In a “game changing” study, UK clinicians have shown that lupus nephritis can be successfully treated without oral steroids by using the immunosuppreant rituximab. The breakthrough may allow patients with lupus to avoid the significant morbidity and … |
Spectrum Pharmaceuticals Acquires Talon Therapeutics, Inc.DailyFinanceThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect of a targeted bio…
|
Empty Decoys Divert Antibodies from Neutralizing Gene Therapy in Cell, Animal …
Science Daily (press release) July 17, 2013 — Gene therapy researchers have produced a bioengineered decoy that fools the immune system and prevents it from mistakenly defeating the benefits delivered by a corrective gene. The decoy was effective in animal studies, and if the … |
Spectrum Pharmaceuticals Acquires Talon Therapeutics, Inc.The Herald | HeraldOnline.comThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect …
Efficacy and safety of concentration-controlled everolimus with reduced-dose …7thSpace Interactive (press release)All patients received basiliximab and corticosteroids. Key endpoints at month 12 were composite efficacy failure (treated biopsy-proven …
Presence of Antibodies to Schmallenberg Virus in a Dog in SwedenJournal of Clinical MicrobiologySchmallenberg virus (SBV) is an orthobunyavirus first discovered in November 2011 in German cattle (1). Since the first descriptions in Germany, SBV has spr…
Lupus Nephritis Tamed Without SteroidsMedPage TodayA combination regimen of rituximab (Rituxan) and mycophenolate mofetil (CellCept) successfully controlled lupus nephritis in 90% of patients without the need for oral corticosteroids, a prospective obs…
New Range of Recombinant Fab Monoclonal Antibodies Launched at AACC 2013Newswire Today (press release)NewswireToday – /newswire/ – Cardiff, Wales, United Kingdom, 2013/07/16 – The AACC Conference and Expo sees the launch of an innovative new range of r…
Industry Today (press release) |
New Range of Recombinant Fab Monoclonal Antibodies Launched at AACC 2013
Industry Today (press release) Cardiff, UK, July 16, 2013 — BBI Solutions, a world leader in immunoassay development and contract manufacturing, will launch its unique range of Recombinant Fab Monoclonal Antibodies on booth #3363 at the American Association for Clinical Chemistry’s … |